ABFM Board Certified in Family Medicine, ABPM Board Certified in Public Health, & General Preventive Medicine
Food and Drug Administration (FDA) in 1990 and 1997, respectively, for the treatment of idiopathic growth hormone deficiency (GHD) in children with growth failure, or for evaluating the ability of the growth hormone producing cells, called somatotrophs, of the pituitary gland to secrete growth hormone
Product Specifications CAS Numbers: Tesamorelin : 218949-48-5 Ipamorelin : 170851-70-4 Peptide Sequences: Tesamorelin: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 Ipamorelin: AibHis-D-2Nal-D-Phe-Lys Molecular Formulas: Tesamorelin: CHNOS Ipamorelin: CHNO Molecular Weights: Tesamorelin: 5136 g/mol Ipamorelin: 711.9 g/mol Synonyms: Tesamorelin: TH9507 Ipamorelin: NNC 26-0161 Category: Peptides Subcategory: Muscle Growth & Performance Peptides Purity: 99% (use lot-specific COA for the exact value) Packaging Format: 1 vial (Tesamorelin (10mg) + Ipamorelin (2mg)) Storage Conditions: Store at -20C, avoid light exposure Key Characteristics of 2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg) Complementary Peptides: A blend of GHRH-analog (Tesamorelin) and GHS-R agonist (Ipamorelin) peptides, frequently used in growth-hormone pathway studies
%20with%20Ipamorelin%20(Growth%20Hormone%20Secretagogue)%3F)
Age-Related Adjustments Age impacts growth hormone production and peptide response: Ages 25-35: Natural GH production still relatively high May respond well to lower doses Focus on optimization rather than replacement Ages 35-50: Declining natural GH production Standard dosing protocols typically optimal Most responsive age group for visible results Ages 50+: Significantly reduced baseline GH May benefit from higher end of dosing range Increased importance of cycling and monitoring Goal-Specific Dosing Different objectives may warrant adjusted dosing strategies : Fat Loss Primary Goal: Moderate to high doses (400-600mcg) Consistent 5-6 day per week schedule Longer cycles (12-16 weeks) Combine with caloric deficit Muscle Gain/Anti-Aging: Moderate doses (300-500mcg) Standard 5 day per week schedule Standard cycles (8-12 weeks) Combine with adequate protein and training Recovery and Sleep: Lower to moderate doses (200-400mcg) Evening administration only Can use longer-term with periodic breaks Body Recomposition: Moderate to high doses (400-600mcg) 5-6 day per week consistency 12-16 week cycles Combine with resistance training Those exploring multiple peptide options should consider how different compounds complement each other, similar to protocols discussed in ideal dose and dosing for GLOW Blend Peptide and ideal dose and dosing for KLOW blend peptide resources
Enhanced Sleep: Its users feel their sleep improves after consuming CJC 1295 and Ipamorelin, which their bodies need to regenerate from their muscles
the IV drip runs 2060 minutes
